DAMORA THERAPEUTICS, INC.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-161.82 | $-198.53 |
| FY2020 | $-7.62 | $-103.88 |
| FY2021 | $-2.05 | $-70.04 |
| FY2022 | $-2.43 | $-53.18 |
| FY2023 | $-36.08 | $-49.98 |
| FY2024 | $-18.53 | $-44.74 |
| FY2025 | $3.98 | $-37.78 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-161.82 | $-198.53 |
| FY2020 | $-7.62 | $-103.88 |
| FY2021 | $-2.05 | $-70.04 |
| FY2022 | $-2.43 | $-53.18 |
| FY2023 | $-36.08 | $-49.98 |
| FY2024 | $-18.53 | $-44.74 |
| FY2025 | $3.98 | $-37.78 |